 These patients are responsive to acetazolamide.Both juvenile myoclonic epilepsy and EA5 are a result of mutations in CACNB4, a gene that encodes the calcium channel β4 subunit.This subunit coassembles with α-subunits and produces channels that slowly inactivate after opening.